CRISPR-based precision molecular diagnostics for disease detection and surveillance

A Kulkarni, S Tanga, A Karmakar, A Hota… - ACS Applied Bio …, 2023 - ACS Publications
Sensitive, rapid, and portable molecular diagnostics is the future of disease surveillance,
containment, and therapy. The recent SARS-CoV-2 pandemic has reminded us of the …

Biomedical relevance of novel anticancer peptides in the sensitive treatment of cancer

OO Bakare, A Gokul, R Wu, LA Niekerk, A Klein… - Biomolecules, 2021 - mdpi.com
The global increase in cancer mortality and economic losses necessitates the cautious
quest for therapeutic agents with compensatory advantages over conventional therapies …

De Novo Discovery of High-Affinity Peptide Binders for the SARS-CoV-2 Spike Protein

S Pomplun, M Jbara, AJ Quartararo, G Zhang… - ACS central …, 2020 - ACS Publications
The β-coronavirus SARS-CoV-2 has caused a global pandemic. Affinity reagents targeting
the SARS-CoV-2 spike protein are of interest for the development of therapeutics and …

Selection for constrained peptides that bind to a single target protein

AM King, DA Anderson, E Glassey… - Nature …, 2021 - nature.com
Peptide secondary metabolites are common in nature and have diverse pharmacologically-
relevant functions, from antibiotics to cross-kingdom signaling. Here, we present a method to …

Computational analysis of spike protein of SARS-CoV-2 (Omicron variant) for development of peptide-based therapeutics and diagnostics

M Pritam, S Dutta, KM Medicherla… - Journal of …, 2023 - Taylor & Francis
In the last few years, the worldwide population has suffered from the SARS-CoV-2
pandemic. The WHO dashboard indicated that around 504,079,039 people were infected …

Antibacterial activity of rationally designed antimicrobial peptides

MB Tincho, T Morris, M Meyer… - International Journal of …, 2020 - Wiley Online Library
Many infectious diseases are still prevalent in the world's populations since no effective
treatments are available to eradicate them. The reasons may either be the antibiotic …

PZQ therapy: how close are we in the development of effective alternative anti-schistosomal drugs?

RT Aruleba, TA Adekiya, BE Oyinloye… - … Current Drug Targets …, 2019 - ingentaconnect.com
Today schistosomiasis, caused mainly by the three major schistosome species (S. mansoni,
S. haematobium and S. japonicum), has for many decades and still continues to be on a …

[HTML][HTML] In silico prediction of new antimicrobial peptides and proteins as druggable targets towards alternative anti-schistosomal therapy

RT Aruleba, MB Tincho, A Pretorius, AP Kappo - Scientific African, 2021 - Elsevier
Schistosomiasis is a debilitating disease caused by a parasitic flatworm found in freshwater.
With the exponential increase in prevalence, Praziquantel (PZQ) remains the only effective …

[PDF][PDF] In silico identification and molecular validation of putative antimicrobial peptides for HIV therapy.

MB Tincho, MN Gabere, A Pretorius - 2016 - researchgate.net
Objective: Despite the effort to reduce the rate of HIV infection, AIDS still remains the major
cause of death around the world, predominantly in Sub-Sahara Africa. Neither a cure, nor an …

Structural and molecular docking analytical studies of the predicted ligand binding sites of cadherin-1 in cancer prognostics

OO Bakare, AO Fadaka, M Keyster… - … and Applications in …, 2020 - Taylor & Francis
Introduction Several studies have explored the design of antimicrobial peptides (AMPs) for
the development of therapeutic and diagnostic molecules for the treatment and identification …